Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Dividends

Explore dividend yields, payout ratios, and historical trends to maximize your investment strategies.

Last Close
May 24 04:00PM ET
Dollar change
Percentage change
IndexRUT P/E- EPS (ttm)-2.17 Insider Own35.09% Shs Outstand33.42M Perf Week-5.14%
Market Cap55.48M Forward P/E- EPS next Y- Insider Trans3.66% Shs Float21.70M Perf Month0.61%
Income-70.71M PEG- EPS next Q-0.13 Inst Own56.52% Short Float14.16% Perf Quarter1.22%
Sales0.00M P/S- EPS this Y67.06% Inst Trans0.31% Short Ratio11.58 Perf Half Y-72.52%
Book/sh2.43 P/B0.68 EPS next Y- ROA-77.06% Short Interest3.07M Perf Year-79.68%
Cash/sh2.48 P/C0.67 EPS next 5Y- ROE-84.01% 52W Range0.98 - 9.45 Perf YTD3.75%
Dividend Est.- P/FCF- EPS past 5Y-50.29% ROI-86.42% 52W High-82.43% Beta0.24
Dividend TTM- Quick Ratio29.82 Sales past 5Y0.00% Gross Margin- 52W Low69.37% ATR (14)0.11
Dividend Ex-Date- Current Ratio29.82 EPS Y/Y TTM1.00% Oper. Margin0.00% RSI (14)44.99 Volatility8.75% 6.51%
Employees8 Debt/Eq0.01 Sales Y/Y TTM- Profit Margin- Recom3.00 Target Price1.50
Option/ShortYes / Yes LT Debt/Eq0.01 EPS Q/Q58.22% Payout- Rel Volume0.51 Prev Close1.73
Sales Surprise- EPS Surprise42.75% Sales Q/Q- EarningsMay 07 BMO Avg Volume265.37K Price1.66
SMA20-4.41% SMA50-2.67% SMA200-58.93% Trades Volume135,156 Change-4.05%
Date Action Analyst Rating Change Price Target Change
Dec-15-23Downgrade Leerink Partners Outperform → Market Perform
Dec-15-23Downgrade Jefferies Buy → Hold
Dec-15-23Downgrade H.C. Wainwright Buy → Neutral $30 → $1.50
Dec-14-23Downgrade William Blair Outperform → Mkt Perform
Dec-14-23Downgrade Robert W. Baird Outperform → Neutral $28 → $3
Dec-14-23Downgrade Piper Sandler Overweight → Neutral $25 → $4
Dec-14-23Downgrade Ladenburg Thalmann Buy → Neutral
Dec-14-23Downgrade BofA Securities Buy → Underperform $23 → $1.45
Nov-15-23Initiated William Blair Outperform $35.55
Aug-28-23Initiated H.C. Wainwright Buy $30
May-16-24 10:01AM
May-13-24 08:25AM
May-07-24 01:53PM
12:53PM Loading…
Mar-28-24 12:53PM
Mar-25-24 07:00AM
Dec-21-23 04:13PM
Dec-15-23 10:19AM
Dec-14-23 12:35PM
Nov-13-23 05:04PM
Nov-02-23 07:50AM
07:50AM Loading…
Oct-25-23 07:50AM
Oct-20-23 01:22PM
Oct-09-23 07:50AM
Oct-06-23 08:30AM
Aug-29-23 07:35AM
Aug-10-23 07:35AM
Jul-27-23 11:19AM
Jun-30-23 08:25AM
Jun-26-23 08:25AM
Jun-15-23 12:44PM
May-31-23 10:38AM
May-21-23 07:42PM
May-12-23 06:00PM
07:45AM Loading…
May-11-23 07:45AM
May-03-23 11:36PM
Mar-27-23 07:30AM
Mar-14-23 07:30AM
Mar-09-23 08:00AM
Mar-03-23 06:07AM
Feb-02-23 07:35AM
Jan-31-23 07:35AM
Dec-04-22 07:12AM
Nov-08-22 07:35AM
Nov-03-22 08:00AM
Sep-14-22 06:02AM
Sep-06-22 08:35AM
Aug-29-22 07:35AM
Aug-09-22 08:00AM
Aug-04-22 09:10AM
Aug-02-22 07:30AM
Jul-26-22 09:52AM
Jul-11-22 08:00AM
Jun-30-22 08:00AM
Jun-20-22 08:33AM
May-10-22 04:05PM
Mar-23-22 04:05PM
Mar-07-22 08:30AM
Feb-02-22 08:00AM
Jan-24-22 08:00AM
Jan-10-22 11:55AM
Dec-22-21 11:04AM
Nov-11-21 04:05PM
Nov-01-21 04:05PM
Oct-14-21 08:00AM
Oct-11-21 02:35PM
Sep-28-21 08:26AM
Sep-09-21 09:12AM
Aug-11-21 05:55AM
Jul-28-21 08:00AM
Jul-12-21 09:30AM
Jul-09-21 08:00AM
Jul-07-21 08:00AM
Jun-29-21 08:00AM
May-20-21 06:00AM
May-19-21 06:00AM
Apr-13-21 08:14AM
Apr-09-21 12:32PM
Apr-08-21 09:42PM
Reneo Pharmaceuticals, Inc. is a clinical-stage company, which engages in the research and development of therapies for rare genetic mitochondrial diseases. The company was founded by Michael G. Grey and Niall O'Donnell on September 22, 2014 and is headquartered in San Diego, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Leonard Braden Michael10% OwnerMay 14 '24Buy1.54414,281639,5782,672,194May 16 08:58 AM
Hall AshleyChief Development OfficerAug 28 '23Option Exercise1.8015,62528,12555,225Aug 29 05:04 PM
Hall AshleyChief Development OfficerAug 28 '23Sale6.2815,62598,05839,600Aug 29 05:04 PM
Novo Holdings A/S10% OwnerJun 23 '23Sale7.10100,000709,7403,330,337Jun 23 07:15 PM